Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study

被引:0
作者
Peter Kamstrup
Pradeesh Sivapalan
Christian Rønn
Ema Rastoder
Daniel Modin
Anna Kjaer Kristensen
Elisabeth Bendstrup
Rikke Sørensen
Tor Biering-Sørensen
Charlotte Suppli Ulrik
Jørgen Vestbo
Jens-Ulrik Jensen
机构
[1] Copenhagen University Hospital Herlev and Gentofte,Section of Respiratory Medicine
[2] University of Copenhagen,Department of Clinical Medicine
[3] Copenhagen University Hospital-Hvidovre,Department of Respiratory Medicine
[4] Manchester University NHS Foundation Trust,The North West Lung Centre, Wythenshawe Hospital
[5] The University of Manchester,Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences
[6] Manchester Academic Health Science Centre,Department of Cardiology
[7] Copenhagen University Hospital Rigshospitalet,Department of Cardiology
[8] Copenhagen University Hospital Herlev and Gentofte,Department Respiratory Disease and Allergy
[9] Aarhus University Hospital,Department of Clinical Medicine
[10] Aarhus University,undefined
来源
Respiratory Research | / 24卷
关键词
Cohort; D-dimer; COPD; Biomarker; All-cause mortality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 126 条
[1]  
Diseases GBD(2020)Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019 Lancet 396 1204-22
[2]  
Injuries C(2021)Prevalence and risk factors of pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease and its impact on outcomes: a systematic review and meta-analysis Eur Rev Med Pharmacol Sci 25 2604-16
[3]  
Wang J(2021)The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: a meta-analysis and systematic review PLoS ONE 16 e0256480-78
[4]  
Ding YM(2013)Cardiovascular comorbidity in COPD: systematic literature review Chest 144 1163-33
[5]  
Fu X(2006)Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism Respiration 73 428-81
[6]  
Zhong Y(2016)COPD and risk of venous thromboembolism and mortality in a general population Eur Respir J 47 473-8
[7]  
Xu W(2010)Venous thromboemboli and exacerbations of COPD Eur Respir J 35 1243-8
[8]  
Ju J(2011)Thrombin generation in chronic obstructive pulmonary disease: dependence on plasma factor composition Thromb Res 128 e24-6
[9]  
Yu M(1994)Hypercoagulability state in patients with chronic obstructive pulmonary disease Chronic Obstr Bronchitis Haemostasis Group Thromb Haemost 72 343-31
[10]  
Ge M(2012)D-dimer levels in stable COPD patients: a case-control study COPD 9 426-51